R&D TDA - 2026 Undergraduate Internship at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

Enrolled in an undergraduate program with a concentration in Biology, Chemistry, Biochemistry, Chemical Engineering, Biomedical Engineering, Mechanical Engineering, or a related discipline
At least one academic term remaining following the completion of the internship
Authorized to work in the United States on a full-time basis (Lilly will not sponsor F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1 visas)
Team player with excellent communication skills (preferred)
Previous laboratory or pharmaceutical research experience in areas such as bioassay development, biological testing of compounds, organic and peptide synthesis, chemical modality, molecular biology, protein expression, purification, characterization, analytical methods, formulation, flow chemistry, project management, drug product design and performance, or drug product manufacturing process development (preferred)

Responsibilities

Work on projects in drug discovery or development, which may include bioassay development, biological testing of compounds, organic and peptide synthesis, chemical modality, molecular biology, protein expression, purification, characterization, analytical methods, and formulation, flow chemistry, project management, drug product design and performance, or drug product manufacturing process development
Actively contribute to the Discovery or Development organization
Build understanding of the pharmaceutical industry and the role of Eli Lilly scientists in delivering innovative medicines

Skills

Bioassay development

Biological testing

Organic synthesis

Peptide synthesis

Molecular biology

Protein expression

Purification

Characterization

Analytical methods

Formulation

Flow chemistry

Project management

Drug product design

Drug product manufacturing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free